Management of Sleepwalking (Somnambulism)
Most adult patients with sleepwalking do not require pharmacologic treatment; instead, prioritize identifying and treating underlying sleep disorders—particularly sleep-disordered breathing—which when successfully managed often completely resolves sleepwalking episodes. 1, 2
Initial Assessment and Risk Stratification
Identify Patients Who Need Active Treatment
- Most sleepwalkers require no treatment beyond safety measures if episodes are infrequent and benign 3
- Active intervention is indicated when sleepwalking causes:
Screen for Underlying Sleep Disorders (Critical Step)
The single most important management step is identifying and treating associated sleep disorders, which are present in the majority of chronic sleepwalkers and constitute the unstable NREM sleep background on which sleepwalking occurs. 1, 4
- Sleep-disordered breathing (SDB) is frequently associated with chronic sleepwalking in adults 1
- Upper airway resistance syndrome (UARS) is present in >90% of sleepwalkers with mild SDB 4
- Other triggers include restless legs syndrome and periodic limb movements 2
- Polysomnography should be obtained to identify these conditions 1, 4
Review Medications That May Trigger Sleepwalking
Discontinue or reduce offending agents when clinically safe 5:
- Benzodiazepine receptor agonists (especially zolpidem—strongest evidence) 5
- Sodium oxybate (strongest evidence after zolpidem) 5
- Antidepressants and serotonergic agents (SSRIs) 5
- Antipsychotics 5
- β-blockers 5
Treatment Algorithm
First-Line: Treat Underlying Sleep Disorders
For sleepwalkers with sleep-disordered breathing:
- Initiate nasal CPAP therapy for SDB/UARS 1
- All CPAP-compliant patients achieved complete control of sleepwalking at all follow-up stages 1
- Non-compliant patients had persistent sleepwalking 1
- For CPAP-intolerant patients, surgical treatment of SDB also resulted in complete resolution of sleepwalking 1
This approach is superior to pharmacotherapy: patients treated with benzodiazepines alone or for psychiatric comorbidities had persistence of sleepwalking, while those treated for underlying sleep disorders achieved control 1
Second-Line: Non-Pharmacologic Interventions
For sleepwalking without identifiable underlying sleep disorder or when episodes persist despite treating comorbid conditions 3, 6:
- Scheduled awakening: Wake the patient 15-30 minutes before typical sleepwalking episodes occur 3
- Hypnosis: May be beneficial, though evidence is limited 3
- Impulse-control interventions for violent sleepwalkers 3
Third-Line: Pharmacologic Treatment
Use only when non-pharmacologic measures fail and risk remains high 6, 2:
Clonazepam is the most commonly used medication 2
Alternative agents with limited evidence 2:
- Tricyclic antidepressants
- SSRIs (though these can also trigger sleepwalking 5)
Important limitation: No properly powered rigorous controlled trials exist for sleepwalking treatment in adults; all pharmacologic recommendations are based on case series and expert opinion 6
Mandatory Safety Measures (Implement Immediately)
Before any other intervention, establish comprehensive bedroom safety 3, 2:
- Remove loaded firearms from sleeping environment
- Lower mattress to floor level
- Pad furniture corners
- Install window locks and protection
- Remove potential weapons (bedside lamps, sharp objects)
- Consider barrier between patient and bed partner or separate sleeping arrangements
- Lock exterior doors and install alarms
Age-Specific Considerations
- Elderly patients have remarkably low odds of sleepwalking compared to adults and children, suggesting different pathomechanisms 7
- When elderly patients present with nocturnal behaviors, consider REM sleep behavior disorder rather than sleepwalking 7
- Adult females perform complex manual activities during sleepwalking more often than males, requiring heightened safety precautions 7
Common Pitfalls to Avoid
- Do not initiate benzodiazepines without first screening for and treating underlying sleep disorders—this is the most common error and leads to treatment failure 1
- Do not assume sleepwalking is benign; falls and major injuries requiring hospitalization occur in approximately 36% of ED presentations for sleepwalking-related trauma 8
- Do not overlook medication-induced sleepwalking, particularly with zolpidem and sodium oxybate 5
- Do not confuse sleepwalking with REM sleep behavior disorder in elderly patients—these require different management approaches 7